Knowledge Center
Article / Jun 01, 2009
Substandard APIs: we must tackle the problem together
Source:
Pharmaceutical Technology Europe, June, 2009
Contrary to what some would have you believe, the use of substandard APIs in European medicines puts patient health and pharmaceutical manufacturers' reputations at risk. Most APIs destined for the EU come from Asian plants that have never been inspected by an EU official. To ensure a minimum level of quality, agencies and regulators from both sides of the Atlantic must work together to provide API compliance oversight.
Related links
Also in the Knowledge Center
/ Sep 18, 2023
Amorphous Nasal Powder Advanced Performance: "In Vitro/Ex Vivo" Studies and Correlation with "In Vivo" Pharmacokinetics
Read more
Scientific Article
Scientific Article
/ Aug 31, 2023
Spray Freeze Drying of Biologics: A Review and Applications for Inhalation Delivery
Read more
Scientific Article